First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Left atrial appendage occlusion

Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

TCT 2021 - WATCHMAN LAAC Closure - Boston Scientific

Left Atrial Appendage (LAA) Occluders

Left Atrial Appendage Closure for Stroke Prevention

WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry

Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions

Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

Current Endocardial Approaches for LAA Closure – touchCARDIO

WATCHMAN FLX™ Device vs Amplatzer™ Amulet™ Occluder: A Meta-Analysis

The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation - ScienceDirect

Structural Heart Occluders

Transcatheter LAA Closure Transcatheter Left Atrial Appendage Closure